Titre : Séquences d'acides nucléiques régulatrices

Séquences d'acides nucléiques régulatrices : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cataract Extraction
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Séquences d'acides nucléiques régulatrices : Questions médicales les plus fréquentes", "headline": "Séquences d'acides nucléiques régulatrices : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Séquences d'acides nucléiques régulatrices : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-21", "dateModified": "2025-04-15", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Séquences d'acides nucléiques régulatrices" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Structures génétiques", "url": "https://questionsmedicales.fr/mesh/D040342", "about": { "@type": "MedicalCondition", "name": "Structures génétiques", "code": { "@type": "MedicalCode", "code": "D040342", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Réseaux de régulation génique", "alternateName": "Gene Regulatory Networks", "url": "https://questionsmedicales.fr/mesh/D053263", "about": { "@type": "MedicalCondition", "name": "Réseaux de régulation génique", "code": { "@type": "MedicalCode", "code": "D053263", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.080.689.360" } } }, { "@type": "MedicalWebPage", "name": "Séquences régulatrices de l'acide ribonucléique", "alternateName": "Regulatory Sequences, Ribonucleic Acid", "url": "https://questionsmedicales.fr/mesh/D038621", "about": { "@type": "MedicalCondition", "name": "Séquences régulatrices de l'acide ribonucléique", "code": { "@type": "MedicalCode", "code": "D038621", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.080.689.687" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Sites internes d'entrée des ribosomes", "alternateName": "Internal Ribosome Entry Sites", "url": "https://questionsmedicales.fr/mesh/D000067556", "about": { "@type": "MedicalCondition", "name": "Sites internes d'entrée des ribosomes", "code": { "@type": "MedicalCode", "code": "D000067556", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.080.689.687.093" } } }, { "@type": "MedicalWebPage", "name": "Riborégulateur", "alternateName": "Riboswitch", "url": "https://questionsmedicales.fr/mesh/D058928", "about": { "@type": "MedicalCondition", "name": "Riborégulateur", "code": { "@type": "MedicalCode", "code": "D058928", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.080.689.687.124" } } } ] }, { "@type": "MedicalWebPage", "name": "Séquence d'encapsidation virale", "alternateName": "Viral Packaging Sequence", "url": "https://questionsmedicales.fr/mesh/D000086502", "about": { "@type": "MedicalCondition", "name": "Séquence d'encapsidation virale", "code": { "@type": "MedicalCode", "code": "D000086502", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.080.689.905" } } } ], "about": { "@type": "MedicalCondition", "name": "Séquences d'acides nucléiques régulatrices", "alternateName": "Regulatory Sequences, Nucleic Acid", "code": { "@type": "MedicalCode", "code": "D012045", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Chad A Mirkin", "url": "https://questionsmedicales.fr/author/Chad%20A%20Mirkin", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Xiaolei Zuo", "url": "https://questionsmedicales.fr/author/Xiaolei%20Zuo", "affiliation": { "@type": "Organization", "name": "Institute of Molecular Medicine, Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127 China." } }, { "@type": "Person", "name": "Qian Li", "url": "https://questionsmedicales.fr/author/Qian%20Li", "affiliation": { "@type": "Organization", "name": "School of Chemistry and Chemical Engineering, Frontiers Science Center for Transformative Molecules, Institute of Translational Medicine, Shanghai Jiao Tong University, Shanghai, 200240 China." } }, { "@type": "Person", "name": "Chunhai Fan", "url": "https://questionsmedicales.fr/author/Chunhai%20Fan", "affiliation": { "@type": "Organization", "name": "Institute of Molecular Medicine, Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127 China." } }, { "@type": "Person", "name": "Hanadi F Sleiman", "url": "https://questionsmedicales.fr/author/Hanadi%20F%20Sleiman", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, McGill University, 801 Sherbrooke St W, Montréal, QC H3A 08B, Canada." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Biometry and corneal aberrations after cataract surgery in childhood.", "datePublished": "2022-05-16", "url": "https://questionsmedicales.fr/article/35524701", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/ceo.14092" } }, { "@type": "ScholarlyArticle", "name": "The Impact of Social Determinants of Health on Vision Loss From Cataracts and Cataract Surgery Utilization in the United States-A National Health Interview Survey Analysis.", "datePublished": "2023-03-23", "url": "https://questionsmedicales.fr/article/36963606", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ajo.2023.03.017" } }, { "@type": "ScholarlyArticle", "name": "Comparison of macular changes and visual outcomes between femtosecond laser-assisted cataract surgery and conventional phacoemulsification surgery for high myopic cataract patients.", "datePublished": "2024-05-15", "url": "https://questionsmedicales.fr/article/38750496", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12886-024-03479-6" } }, { "@type": "ScholarlyArticle", "name": "Temporally consistent sequence-to-sequence translation of cataract surgeries.", "datePublished": "2023-05-23", "url": "https://questionsmedicales.fr/article/37219806", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11548-023-02925-y" } }, { "@type": "ScholarlyArticle", "name": "Management of patients undergoing cataract surgery: An Italian survey.", "datePublished": "2022-12-12", "url": "https://questionsmedicales.fr/article/36503281", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/11206721221145055" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes génétiques", "item": "https://questionsmedicales.fr/mesh/D055614" }, { "@type": "ListItem", "position": 3, "name": "Structures génétiques", "item": "https://questionsmedicales.fr/mesh/D040342" }, { "@type": "ListItem", "position": 4, "name": "Séquences d'acides nucléiques régulatrices", "item": "https://questionsmedicales.fr/mesh/D012045" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Séquences d'acides nucléiques régulatrices - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Séquences d'acides nucléiques régulatrices", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Séquences d'acides nucléiques régulatrices", "description": "Comment identifier une séquence régulatrice ?\nQuels tests sont utilisés pour analyser les séquences régulatrices ?\nPeut-on détecter des mutations dans ces séquences ?\nQuels marqueurs sont associés aux séquences régulatrices ?\nComment évaluer l'activité d'une séquence régulatrice ?", "url": "https://questionsmedicales.fr/mesh/D012045?mesh_terms=Cataract+Extraction&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Séquences d'acides nucléiques régulatrices", "description": "Quels symptômes sont liés à des anomalies régulatrices ?\nLes séquences régulatrices affectent-elles le développement ?\nPeut-on observer des symptômes neurologiques ?\nLes troubles hormonaux sont-ils liés à ces séquences ?\nY a-t-il des symptômes immunologiques associés ?", "url": "https://questionsmedicales.fr/mesh/D012045?mesh_terms=Cataract+Extraction&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Séquences d'acides nucléiques régulatrices", "description": "Comment prévenir les maladies liées aux séquences régulatrices ?\nLes conseils génétiques sont-ils utiles ?\nPeut-on éviter les mutations par des choix de vie ?\nLes vaccinations jouent-elles un rôle ?\nY a-t-il des programmes de sensibilisation ?", "url": "https://questionsmedicales.fr/mesh/D012045?mesh_terms=Cataract+Extraction&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Séquences d'acides nucléiques régulatrices", "description": "Quels traitements ciblent les séquences régulatrices ?\nPeut-on corriger des mutations régulatrices ?\nLes traitements sont-ils personnalisés ?\nQuels sont les défis des traitements ?\nY a-t-il des essais cliniques en cours ?", "url": "https://questionsmedicales.fr/mesh/D012045?mesh_terms=Cataract+Extraction&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Séquences d'acides nucléiques régulatrices", "description": "Quelles complications peuvent survenir ?\nLes complications sont-elles héréditaires ?\nComment les complications sont-elles gérées ?\nY a-t-il des risques de récidive ?\nLes complications affectent-elles la qualité de vie ?", "url": "https://questionsmedicales.fr/mesh/D012045?mesh_terms=Cataract+Extraction&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Séquences d'acides nucléiques régulatrices", "description": "Quels sont les facteurs de risque génétiques ?\nL'environnement influence-t-il ces séquences ?\nLe mode de vie joue-t-il un rôle ?\nLes infections sont-elles un facteur de risque ?\nY a-t-il des facteurs de risque liés à l'âge ?", "url": "https://questionsmedicales.fr/mesh/D012045?mesh_terms=Cataract+Extraction&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier une séquence régulatrice ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'identification se fait par des techniques comme la PCR et le séquençage." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour analyser les séquences régulatrices ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme l'empreinte génétique et l'analyse de l'expression génique sont utilisés." } }, { "@type": "Question", "name": "Peut-on détecter des mutations dans ces séquences ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des mutations peuvent être détectées par séquençage ciblé ou NGS." } }, { "@type": "Question", "name": "Quels marqueurs sont associés aux séquences régulatrices ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les marqueurs épigénétiques comme la méthylation de l'ADN sont souvent associés." } }, { "@type": "Question", "name": "Comment évaluer l'activité d'une séquence régulatrice ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'activité peut être évaluée par des essais de reporter génique." } }, { "@type": "Question", "name": "Quels symptômes sont liés à des anomalies régulatrices ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies peuvent entraîner des maladies génétiques, des cancers ou des troubles métaboliques." } }, { "@type": "Question", "name": "Les séquences régulatrices affectent-elles le développement ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles jouent un rôle crucial dans le développement embryonnaire et cellulaire." } }, { "@type": "Question", "name": "Peut-on observer des symptômes neurologiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Certaines mutations régulatrices peuvent être liées à des troubles neurologiques." } }, { "@type": "Question", "name": "Les troubles hormonaux sont-ils liés à ces séquences ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des séquences régulatrices peuvent influencer la régulation hormonale." } }, { "@type": "Question", "name": "Y a-t-il des symptômes immunologiques associés ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies peuvent entraîner des dysfonctionnements du système immunitaire." } }, { "@type": "Question", "name": "Comment prévenir les maladies liées aux séquences régulatrices ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par le dépistage génétique et la sensibilisation aux facteurs de risque." } }, { "@type": "Question", "name": "Les conseils génétiques sont-ils utiles ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils aident à évaluer le risque et à prendre des décisions éclairées." } }, { "@type": "Question", "name": "Peut-on éviter les mutations par des choix de vie ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Certains choix de vie, comme l'alimentation et l'exercice, peuvent réduire les risques." } }, { "@type": "Question", "name": "Les vaccinations jouent-elles un rôle ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations peuvent prévenir des infections qui influencent l'expression génique." } }, { "@type": "Question", "name": "Y a-t-il des programmes de sensibilisation ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des programmes éducatifs sensibilisent aux maladies génétiques et à leur prévention." } }, { "@type": "Question", "name": "Quels traitements ciblent les séquences régulatrices ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies géniques et des médicaments ciblant des voies spécifiques sont en développement." } }, { "@type": "Question", "name": "Peut-on corriger des mutations régulatrices ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques comme CRISPR permettent de corriger certaines mutations." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la médecine personnalisée adapte les traitements selon le profil génétique." } }, { "@type": "Question", "name": "Quels sont les défis des traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les défis incluent la spécificité, l'efficacité et les effets secondaires potentiels." } }, { "@type": "Question", "name": "Y a-t-il des essais cliniques en cours ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, de nombreux essais cliniques explorent des thérapies ciblant ces séquences." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des cancers, des troubles métaboliques et des maladies auto-immunes." } }, { "@type": "Question", "name": "Les complications sont-elles héréditaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être héréditaires, liées à des mutations dans les séquences régulatrices." } }, { "@type": "Question", "name": "Comment les complications sont-elles gérées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La gestion implique un suivi médical régulier et des traitements adaptés." } }, { "@type": "Question", "name": "Y a-t-il des risques de récidive ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles peuvent avoir un risque de récidive, nécessitant une surveillance." } }, { "@type": "Question", "name": "Les complications affectent-elles la qualité de vie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent significativement impacter la qualité de vie des patients." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque génétiques ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des antécédents familiaux de maladies génétiques augmentent le risque." } }, { "@type": "Question", "name": "L'environnement influence-t-il ces séquences ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs environnementaux comme les toxines peuvent affecter l'expression génique." } }, { "@type": "Question", "name": "Le mode de vie joue-t-il un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes comme le tabagisme et l'alimentation peuvent influencer le risque." } }, { "@type": "Question", "name": "Les infections sont-elles un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections peuvent déclencher des modifications dans les séquences régulatrices." } }, { "@type": "Question", "name": "Y a-t-il des facteurs de risque liés à l'âge ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de maladies génétiques augmente avec l'âge." } } ] } ] }

Sources (10000 au total)

Biometry and corneal aberrations after cataract surgery in childhood.

To report long-term biometric and refractive outcomes in a group of Danish children after surgery for childhood cataract.... Children between 7 and 18 years who had undergone uni- or bilateral cataract surgery at the Department of Ophthalmology, Rigshospitalet, Denmark, were examined in this cross-sectional study. Swept sou... We included 56 children in the study with a median age at surgery of 43.8 months (1.6-137.6). The amount of higher order aberrations was significantly increased in operated eyes (median root mean squa... Eyes operated for childhood cataract have higher order aberrations compared with non-operated eyes. Higher order aberrations are complex refractive errors that cannot be corrected by normal lenses and...

The Impact of Social Determinants of Health on Vision Loss From Cataracts and Cataract Surgery Utilization in the United States-A National Health Interview Survey Analysis.

To investigate the association of social determinants of health (SDOH) factors and cataract-related outcomes disparities.... Cross-sectional, with a nationally representative sample.... We used publicly available data from the 2008, 2016, and 2017 National Health Interview Survey data sets. Outcome measures included self-reported prevalence for ever been diagnosed with cataract, visi... A total of 81,551 participants were included, who were predominantly between 18 and 44 years of age (49.6%), female (51.7%), and White (74.8%). Multivariable regression models with age as a covariate ... Several SDOH factors were associated with disparities in rates of cataract-related outcomes. These findings highlight the importance of ophthalmologists screening for social risks in patients with cat...

Comparison of macular changes and visual outcomes between femtosecond laser-assisted cataract surgery and conventional phacoemulsification surgery for high myopic cataract patients.

To evaluate differences in log MAR best-corrected visual acuity (BCVA) improvement and postoperative central foveal thickness (CFT) and choroidal thickness (CT) changes between conventional phacoemuls... This was a retrospective and observational study. One hundred and two eyes of 102 patients with high-myopia cataracts were examined. CPS was performed in 54 eyes, and FLACS was performed in 48 eyes. A... The logMAR BCVA improved significantly after surgery in both groups (both P < 0.001), but no difference was observed in BCVA improvement between the groups (P = 0.554). Moreover, no significant differ... FLACS was not superior to CPS in improving BCVA but had less impact on SFCT in the treatment of high-myopia cataracts. Eyes with a longer AL, worse preoperative logMAR BCVA and thinner SFCT had a high...

Temporally consistent sequence-to-sequence translation of cataract surgeries.

Image-to-image translation methods can address the lack of diversity in publicly available cataract surgery data. However, applying image-to-image translation to videos-which are frequently used in me... We introduce a motion-translation module that translates optical flows between domains to impose such constraints. We combine it with a shared latent space translation model to improve image quality. ... Our proposed method produces more consistent translations than state-of-the-art baselines. Moreover, it stays competitive in terms of the per-image translation quality. We further show the benefit of ... The proposed module increases the temporal consistency of translated sequences. Furthermore, imposed temporal constraints increase the usability of translated data in downstream tasks. This allows ove...

Management of patients undergoing cataract surgery: An Italian survey.

To investigate the management of patients undergoing cataract surgery in Italy.... Italian ocular surgeons, members of the Italian Association of Cataract and Refractive Surgery (AICCER), were invited to participate to this survey.... Participants had to respond to a questionary including a series of practical questions concerning the management of patients undergoing cataract surgery.... A designed questionnaire explored the main issues concerning the practical problems involved in managing patients undergoing cataract surgery. The questionnaire was sent by e-mail and analyzed by desc... Preoperative prophylaxis was performed by most surgeons. After surgery, several products were used, even simultaneously. Fixed antibiotic-corticosteroid combination (87.2%; 89) and NSAIDs (88.2; 90) w... This survey confirmed a discrete adherence to the main guidelines but at the same time highlights a discrete inhomogeneity in the use of medications, duration of treatments, and follow-up visits. For ...

The output of cataract surgery performed by trained non-ophthalmologist physicians in rural areas: study of cataract outcomes and up-take of services report 7.

Cataract is the leading cause of blindness worldwide and surgery can restore vision in most patients. Some patients have little access to surgical services due to lack of cataract surgeons and the una... We conducted a retrospective cohort study to analyze patients' hand-written medical records and electronic outpatient record between January 2005 and December 2019 at two rural health clinics in South... In total, 34,601 patients (49,942 eyes) underwent cataract surgery by non-ophthalmologist physicians from 2005 to 2019.Visual acuity was clearly documented in 38,251 eyes. Before surgery, the unaided ... Non-ophthalmologist physicians trained for cataract surgeries in rural clinics can improve cataract related visual acuity and basic eye care to the local population....

Significant improvements in cataract treatment and persistent inequalities in access to cataract surgery among older Poles from 2009 to 2019: results of the PolSenior and PolSenior2 surveys.

Cataract is the leading cause of visual impairment and blindness among older adults worldwide, that can be corrected through surgical interventions. However, diagnosis and treatment bias can be observ... An analysis based on a survey among 4,905 participants of the nationwide PolSenior study conducted in 2008-2009, and 5,031 participants of PolSenior2 conducted one decade later to assess the health of... Cataract diagnosis was declared by 25.5 and 28.2% of the study population in PolSenior and PolSenior2 surveys, respectively. Out of those diagnosed with cataract in PolSenior, 46.5% underwent surgical... Although the prevalence of cataract in the older adult population in Poland has not changed from 2009 to 2019, the rate of cataract surgeries has considerably increased over the analyzed decade. Patie...

Efficacy of femtosecond laser for anterior capsulotomy in complex white cataracts.

To determine the advantages and complication rate of capsulotomy performed with femtosecond laser in white complex cataract cases.... Retrospective case series.... Sixteen eyes of 16 patients.... This was a single-center retrospective review of white cataract surgery cases in which the femtosecond laser (LenSx, Alcon Laboratories, Fortworth, Texas, USA) was used between May 2019 and February 2... Sixteen eyes of 16 patients were included in this study; capsule tags occurred in six patients (37.5%). In 2 patients, the capsule presented small adhesions that were identified and removed. One patie... The femtosecond laser permitted capsulotomies of better shape, size and regularity in complex cases of white cataract and in combination with conditions such as nystagmus and prior corneal transplanta...

Efficacy and safety of the eight-chop technique in phacoemulsification for patients with cataract.

The aim of this study was to estimate the efficacy of the 8-chop technique in phacoemulsification surgeries of patients with cataract.... Sato Eye Clinic, Chiba-ken, Japan.... Prospective study.... Patients were classified into 3 groups (Grade II, Grade III, and Grade IV; n = 50 each) according to the firmness of their lens nuclei. The Eight-chopper I was used for Grade II, Eight-chopper II for ... 150 cataract surgeries were performed. The operative time (minutes), phaco time (seconds), CDE, and volume of fluid used (milliliters) differed significantly among the 3 groups, increasing in the foll... The 8-chop technique was effective and safe in phacoemulsification for patients with cataracts with lens nuclei of varying hardness....